TLX Insider Trading Activity and SEC Form 4 Filings
TLX insider trading summary
Over the past 12 months, insiders at Telix Pharmaceuticals Ltd (TLX) reported 3 open-market purchases worth $1.0M by 2 insiders and no sales on SEC Form 4. Net insider buying was $1.0M.
Latest TLX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 7, 2026 | Darren Charlton Smith | Group Chief Financial Officer | Buy | $20K (2,071 @ $9.66) |
| Apr 29, 2026 | Christian Behrenbruch | MD & Group CEO | Buy | $497K (33,435 @ $14.87) |
| Apr 28, 2026 | Christian Behrenbruch | MD & Group CEO | Buy | $500K (34,500 @ $14.48) |
| May 1, 2006 | John A Long | Senior Vice President | Sell | $6K (1,000 @ $6.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.